O
Oncozenge AB
STO:ONCOZ
Oncozenge AB
STO:ONCOZ
Price:
5.58
SEK
3.53%
Market Cap:
kr70.6m
Relative Value
The Relative Value of one ONCOZ stock under the Base Case scenario is hidden SEK. Compared to the current market price of 5.58 SEK, Oncozenge AB is hidden .
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
ONCOZ Relative Value
HIDDEN
Multiples Across Competitors
ONCOZ Competitors Multiples
Oncozenge AB Competitors
Oncozenge AB Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| SE |
O
|
Oncozenge AB
STO:ONCOZ
|
70.6m SEK | 26 | -8.2 | -7.8 | -7.8 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
997.2B USD | 15.3 | 48.3 | 32.5 | 34.6 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
578.6B USD | 6.1 | 21.6 | 15 | 18.4 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
281.8B CHF | 4.6 | 30 | 12.7 | 14.8 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
303.5B USD | 4.7 | 16.6 | 10.4 | 12.1 | |
| CH |
|
Novartis AG
SIX:NOVN
|
231.3B CHF | 5.3 | 21.3 | 13.1 | 16.9 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
218.1B GBP | 5.2 | 32.1 | 15.3 | 22.4 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.4T DKK | 4.6 | 13.7 | 10 | 11.8 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
218B USD | 94 | -74.6 | 333.1 | 835.4 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
154.7B USD | 2.5 | 19.9 | 7.4 | 9.9 | |
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
125.6B USD | 2.6 | 17.8 | 6.9 | 8.9 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
